Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells.
about
Improved endpoints for cancer immunotherapy trialsSafety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trialEnzyme-linked immunospot assay for detection of human respiratory syncytial virus f protein-specific gamma interferon-producing T cells.Modeling flow cytometry data for cancer vaccine immune monitoring.Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program.Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer stainingMerkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI)Extracellular milieu grossly alters pathogen-specific immune response of mammary epithelial cells.Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa studyELISpot for measuring human immune responses to vaccines.Harmonization of immune biomarker assays for clinical studies.Immunological Monitoring to Rationally Guide AAV Gene Therapy.Standardized Serum-Free Cryomedia Maintain Peripheral Blood Mononuclear Cell Viability, Recovery, and Antigen-Specific T-Cell Response Compared to Fetal Calf Serum-Based MediumSerum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study.Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis.Characterization of T-cell responses to cryptic epitopes in recipients of a noncodon-optimized HIV-1 vaccineStepping up ELISpot: Multi-Level Analysis in FluoroSpot AssaysHarmonization of the intracellular cytokine staining assay.Guidelines for the automated evaluation of Elispot assays.
P2860
Q24603112-C35A61AF-8CD3-428C-BFB5-8D9759AD4F00Q28483626-DF5D14FA-F678-4CA2-93BA-DA487A4A32B6Q33601830-A334F75C-AD61-4F42-91FA-755F8391374EQ33610175-4C95A471-BCB5-40F1-81C2-A5B743657429Q33619141-3F197C22-4019-49A4-88C0-A736CE04D11EQ34333155-A2EB4CA1-FE15-443D-AAD1-A9EFD1DDCB2AQ34402469-B19AA6A0-6B2D-42A1-BC58-696F20B445E8Q35510910-6EC75B64-F3F8-4E31-AF90-A78113EB0AF1Q35646739-4CC3BA42-8080-43AE-BE1E-0DCC1FEE54D4Q35720894-877DFC57-FD30-4DD4-8914-D617AA59E486Q35746834-0A3BA09E-62E3-4844-9DC8-C8F4E5D9CB4BQ37857243-EFCAF4D6-1178-44B9-8362-6317E5A2E835Q37954593-D5B30DCA-99FC-4976-A0C4-3B4FCB7A127BQ38142098-949D411C-E472-470D-AA13-9E234B95E6ECQ38544409-83406073-51F9-4C30-B83B-FA413131B306Q39784050-87376596-51F0-4E2E-A430-5102386F6418Q41550516-7F9DA35B-CF9D-4E78-AFFA-17BC153F8CA4Q41642827-5D04C0B4-BD80-47B6-A4B3-AE6F44E164D4Q41881198-E6AB82A3-D258-464D-BE8E-4727B364FF0CQ42055826-10AF3176-EA58-480A-8745-078DD0798424Q42207308-CA9312C2-58E4-4B5B-9A7D-BC8EA51E165FQ49020806-DFC0679F-1F04-41D5-82A6-F01ACF7AE5F6
P2860
Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Performance of serum-supplemen ...... spot Assays for human T cells.
@ast
Performance of serum-supplemen ...... spot Assays for human T cells.
@en
type
label
Performance of serum-supplemen ...... spot Assays for human T cells.
@ast
Performance of serum-supplemen ...... spot Assays for human T cells.
@en
prefLabel
Performance of serum-supplemen ...... spot Assays for human T cells.
@ast
Performance of serum-supplemen ...... spot Assays for human T cells.
@en
P2093
P2860
P1476
Performance of serum-supplemen ...... spot Assays for human T cells.
@en
P2093
C Gouttefangeas
C M Britten
E Kaempgen
J Caterini
J R Currier
K Nihlmark
S H van der Burg
P2860
P2888
P304
P356
10.1007/S00262-009-0788-2
P577
2009-11-06T00:00:00Z
P5875
P6179
1022837896